Postnatal fluoxetine-evoked anxiety is prevented by concomitant 5-HT2A/C receptor blockade and mimicked by postnatal 5-HT2A/C receptor stimulation

Biological Psychiatry

Volumn 76, Issue 11, 2014, Pages 858-868

  Sarkar, Ambalika ^a   Chachra, Parul ^a   Vaidya, Vidita A ^a  

^a TATA INSTITUTE OF FUNDAMENTAL RESEARCH   (India)

Author keywords

5 HT1A; 5 HT2A; 5 HT2C ketanserin; Antidepressant; DOI; Prozac; SSRI; WAY 100635

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE; 6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; FLUOXETINE; KETANSERIN; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; VOLINANSERIN; SEROTONIN 2 AGONIST; SEROTONIN 2 ANTAGONIST; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CONTROLLED STUDY; DEPRESSION; GENE EXPRESSION; MALE; NONHUMAN; POSTNATAL CARE; PREFRONTAL CORTEX; RAT; RECEPTOR BLOCKING; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; METABOLISM; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANXIETY; DEPRESSION; FLUOXETINE; GENE EXPRESSION; MALE; MOTOR ACTIVITY; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTOR, SEROTONIN, 5-HT2C; SEROTONIN 5-HT2 RECEPTOR AGONISTS; SEROTONIN 5-HT2 RECEPTOR ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 84911396778     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2013.11.005     Document Type: Article

References (79)

1. C. Gross, and R. Hen The developmental origins of anxiety Nat Rev Neurosci 5 2004 545 552
2. P. Gaspar, O. Cases, and L. Maroteaux The developmental role of serotonin: News from mouse molecular genetics Nat Rev Neurosci 4 2003 1002 1012
3. R. Nonacs, and L.S. Cohen Assessment and treatment of depression during pregnancy: An update Psychiatr Clin North Am 26 2003 547 562
4. I. Kodish, C. Rockhill, and C. Varley Pharmacotherapy for anxiety disorders in children and adolescents Dialogues Clin Neurosci 13 2011 439 452
5. J. Rampono, K. Simmer, K.F. Ilett, L.P. Hackett, D.A. Doherty, and R. Elliot Placental transfer of SSRI and SNRI antidepressants and effects on the neonate Pharmacopsychiatry 42 2009 95 100
6. J.F. Wernicke Safety and side effect profile of fluoxetine Expert Opin Drug Saf 3 2004 495 504
7. H. Nordeng, R. Lindemann, K.V. Perminov, and A. Reikvam Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors Acta Paediatr 90 2001 288 291
8. E.J. Mulder, F.F. Ververs, R. de Heus, and G.H. Visser Selective serotonin reuptake inhibitors affect neurobehavioral development in the human fetus Neuropsychopharmacology 36 2011 1961 1971
9. H. Malm Prenatal exposure to selective serotonin reuptake inhibitors and infant outcome Ther Drug Monit 34 2012 607 614
10. A. Cipriani, C. Barbui, and J.R. Geddes Suicide, depression, and antidepressants BMJ 330 2005 373 374
11. J.D.A. Olivier, T. Blom, T. Arentsen, and J.R. Homberg The age-dependent effects of selective serotonin reuptake inhibitors in humans and rodents: A review Prog Neuropsychopharmacol Biol Psychiatry 35 2011 1400 1408
12. B. Clancy, B.L. Finlay, R.B. Darlington, and K.J. Anand Extrapolating brain development from experimental species to humans Neurotoxicology 28 2007 931 937
13. M.S. Ansorge, E. Morelli, and J.A. Gingrich Inhibition of serotonin but not norepinephrine transport during development produces delayed, persistent perturbations of emotional behaviors in mice J Neurosci 28 2008 199 207
14. M.S. Ansorge, M. Zhou, A. Lira, R. Hen, and J.A. Gingrich Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice Science 306 2004 879 881
15. N.N. Karpova, J. Lindholm, P. Pruunsild, T. Timmusk, and E. Castren Long-lasting behavioural and molecular alterations induced by early postnatal fluoxetine exposure are restored by chronic fluoxetine treatment in adult mice Eur Neuropsychopharmacol 19 2009 97 108
16. P. Benfield, R.C. Heel, and S.P. Lewis Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness Drugs 32 1986 481 508
17. S.C. Dulawa, K.A. Holick, B. Gundersen, and R. Hen Effects of chronic fluoxetine in animal models of anxiety and depression Neuropsychopharmacology 29 2004 1321 1330
18. J.P. Scott Critical periods in behavioral development Science 138 1962 949 958
19. A.T. Bifulco, G.W. Brown, and T.O. Harris Childhood loss of parent, lack of adequate parental care and adult depression: A replication J Affect Disord 12 1987 115 128
20. M.S. Ansorge, R. Hen, and J.A. Gingrich Neurodevelopmental origins of depressive disorders Curr Opin Pharmacol 7 2007 8 17
21. N.M. Barnes, and T. Sharp A review of central 5-HT receptors and their function Neuropharmacology 38 1999 1083 1152
22. M.S. Lidow, and P. Rakic Scheduling of monoaminergic neurotransmitter receptor expression in the primate neocortex during postnatal development Cereb Cortex 2 1992 401 416
23. 1c mRNA and receptor levels Brain Res Dev Brain Res 58 1991 51 58
24. S.L. Handley, and J.W. McBlane 5HT drugs in animal models of anxiety Psychopharmacology (Berl) 112 1993 13 20
25. (1A) receptors alters adult anxiety behavior and benzodiazepine sensitivity Biol Psychiatry 67 2010 309 316
26. M. Benekareddy, K.C. Vadodaria, A.R. Nair, and V.A. Vaidya Postnatal serotonin type 2 receptor blockade prevents the emergence of anxiety behavior, dysregulated stress-induced immediate early gene responses, and specific transcriptional changes that arise following early life stress Biol Psychiatry 70 2011 1024 1032
27. 2A receptor signaling modulates anxiety-like behaviors in mice Science 313 2006 536 540
28. L.K. Heisler, L. Zhou, P. Bajwa, J. Hsu, and L.H. Tecott Serotonin 5-HT(2C) receptors regulate anxiety-like behavior Genes Brain Behav 6 2007 491 496
29. 1A receptor acts during development to establish normal anxiety-like behaviour in the adult Nature 416 2002 396 400
30. J.W. Richardson-Jones, C.P. Craige, T.H. Nguyen, H.F. Kung, A.M. Gardier, and A. Dranovsky Serotonin-1A autoreceptors are necessary and sufficient for the normal formation of circuits underlying innate anxiety J Neurosci 31 2011 6008 6018
31. 1A autoreceptor levels determine vulnerability to stress and response to antidepressants Neuron 65 2010 40 52
32. 1a autoreceptors on anxiety and social behavior [published online ahead of print August 2] Neuropsychopharmacology 2013
33. 1A knock-out mice J Neurosci 28 2008 6250 6257
34. A. Holmes Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease Neurosci Biobehav Rev 32 2008 1293 1314
35. T. Sharp, L. Boothman, J. Raley, and P. Queree Important messages in the 'post': Recent discoveries in 5-HT neurone feedback control Trends Pharmacol Sci 28 2007 629 636
36. 1A binding in rat brain - a combined in situ hybridisation/in vitro receptor autoradiographic study Brain Res 561 1991 51 60
37. 2A receptors in the stress-induced down-regulation of brain-derived neurotrophic factor expression in rat hippocampus Neurosci Lett 262 1999 1 4
38. 2C receptor involvement in the control of persistence in the reinforced spatial alternation animal model of obsessive-compulsive disorder Behav Brain Res 243 2013 176 183
39. L. Prut, and C. Belzung The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review Eur J Pharmacol 463 2003 3 33
40. S. Pellow, and S.E. File Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: A novel test of anxiety in the rat Pharmacol Biochem Behav 24 1986 525 529
41. M.J. Detke, M. Rickels, and I. Lucki Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants Psychopharmacology (Berl) 121 1995 66 72
42. A.L. Bookout, and D.J. Mangelsdorf Quantitative real-time PCR protocol for analysis of nuclear receptor signaling pathways Nucl Recept Signal 1 2003 e012
43. H.E. Covington 3rd, M.K. Lobo, I. Maze, V. Vialou, J.M. Hyman, and S. Zaman Antidepressant effect of optogenetic stimulation of the medial prefrontal cortex J Neurosci 30 2010 16082 16090
44. J.R. Homberg, D. Schubert, and P. Gaspar New perspectives on the neurodevelopmental effects of SSRIs Trends Pharmacol Sci 31 2010 60 65
45. A. Holmes, R.J. Yang, D.L. Murphy, and J.N. Crawley Evaluation of antidepressant-related behavioral responses in mice lacking the serotonin transporter Neuropsychopharmacology 27 2002 914 923
46. A. Holmes, D.L. Murphy, and J.N. Crawley Abnormal behavioral phenotypes of serotonin transporter knockout mice: Parallels with human anxiety and depression Biol Psychiatry 54 2003 953 959
47. R.S. Heiming, and N. Sachser Consequences of serotonin transporter genotype and early adversity on behavioral profile - pathology or adaptation? Front Neurosci 4 2010 187
48. P.M. Whitaker-Azmitia Behavioral and cellular consequences of increasing serotonergic activity during brain development: A role in autism? Int J Dev Neurosci 23 2005 75 83
49. K.P. Lesch, N. Araragi, J. Waider, D. van den Hove, and L. Gutknecht Targeting brain serotonin synthesis: Insights into neurodevelopmental disorders with long-term outcomes related to negative emotionality, aggression and antisocial behaviour Philos Trans R Soc Lond B Biol Sci 367 2012 2426 2443
50. E. Akimova, R. Lanzenberger, and S. Kasper The serotonin-1A receptor in anxiety disorders Biol Psychiatry 66 2009 627 635
51. B.E. Leonard Serotonin receptors and their function in sleep, anxiety disorders and depression Psychother Psychosom 65 1996 66 75
52. 2 receptors and anxiety Drug Dev Res 65 2005 133 140
53. M. Benekareddy, N.M. Goodfellow, E.K. Lambe, and V.A. Vaidya Enhanced function of prefrontal serotonin 5-HT(2) receptors in a rat model of psychiatric vulnerability J Neurosci 30 2010 12138 12150
54. 2 receptors in the adult offspring J Neurosci 31 2011 1863 1872
55. 2 ligands on three mouse models of anxiety Behav Brain Res 140 2003 203 214
56. 2A agonist DOI Behav Brain Res 204 2009 200 205
57. 2A receptors Eur J Pharmacol 334 1997 25 29
58. V. Motta, S. Maisonnette, S. Morato, P. Castrechini, and M.L. Brandao Effects of blockade of 5-HT2 receptors and activation of 5-HT1A receptors on the exploratory activity of rats in the elevated plus-maze Psychopharmacology (Berl) 107 1992 135 139
59. 2 receptors Psychopharmacology (Berl) 93 1987 502 506
60. G. Griebel, G. Perrault, and D.J. Sanger A comparative study of the effects of selective and non-selective 5-HT2 receptor subtype antagonists in rat and mouse models of anxiety Neuropharmacology 36 1997 793 802
61. 2c receptors in rodent models of potential anxiolytic properties Behav Pharmacol 9 1998 S18
62. H. Cohen Anxiolytic effect and memory improvement in rats by antisense oligodeoxynucleotide to 5-hydroxytryptamine-2A precursor protein Depress Anxiety 22 2005 84 93
63. 2 receptor activation in the midbrain periaqueductal grey (PAG) reduces anxiety-like behaviour in mice Behav Brain Res 187 2008 72 79
64. E.S. da Silva, S.C. Poltronieri, J.O. Nascimento, H. Zangrossi Jr, and M.B. Viana Facilitation of 5-HT(2A/2C)-mediated neurotransmission in the ventromedial hypothalamic nucleus decreases anxiety in the elevated T-maze Behav Brain Res 216 2011 692 698
65. A.P. de Mello Cruz, G. Pinheiro, S.H. Alves, G. Ferreira, M. Mendes, and L. Faria Behavioral effects of systemically administered MK-212 are prevented by ritanserin microinfusion into the basolateral amygdala of rats exposed to the elevated plus-maze Psychopharmacology (Berl) 182 2005 345 354
66. 1 serotonin receptor subtypes during fetal and early postnatal mouse forebrain development Neuroscience 141 2006 781 794
67. 1A receptor binding sites in some areas of the rat CNS during postnatal development Int J Dev Neurosci 5 1987 171 180
68. J. de Almeida, and G. Mengod Serotonin 1A receptors in human and monkey prefrontal cortex are mainly expressed in pyramidal neurons and in a GABAergic interneuron subpopulation: implications for schizophrenia and its treatment J Neurochem 107 2008 488 496
69. 2 receptor family mRNAs: Comparison between 5-HT2A and 5-HT2C receptors Brain Res Mol Brain Res 23 1994 163 178
70. Z.-W. Zhang Serotonin induces tonic firing in layer V pyramidal neurons of rat prefrontal cortex during postnatal development J Neurosci 23 2003 3373 3384
71. N.M. Goodfellow, M. Benekareddy, V.A. Vaidya, and E.K. Lambe Layer II/III of the prefrontal cortex: Inhibition by the serotonin 5-HT1A receptor in development and stress J Neurosci 29 2009 10094 10103
72. E.K. Lambe, S.G. Fillman, M.J. Webster, and C. Shannon Weickert Serotonin receptor expression in human prefrontal cortex: Balancing excitation and inhibition across postnatal development PLoS One 6 2011 e22799
73. J.-C. Beique, B. Campbell, P. Perring, M.W. Hamblin, P. Walker, L. Mladenovic, and R. Andrade Serotonergic regulation of membrane potential in developing rat prefrontal cortex: Coordinated expression of 5-hydroxytryptamine (5-HT)1A, 5-HT2A, and 5-HT7 receptors J Neurosci 24 2004 4807 4817
74. M. Amargos-Bosch, A. Bortolozzi, M.V. Puig, J. Serrats, A. Adell, and P. Celada Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex Cereb Cortex 14 2004 281 299
75. R. Araneda, and R. Andrade 5-Hydroxytryptamine2 and 5-hydroxytryptamine 1A receptors mediate opposing responses on membrane excitability in rat association cortex Neuroscience 40 1991 399 412
76. C.R. Ashby, E. Edwards, and R.Y. Wang Electrophysiological evidence for a functional interaction between 5-HT(1A) and 5-HT(2A) receptors in the rat medial prefrontal cortex: An iontophoretic study Synapse 17 1994 173 181
77. P.M. Fisher, J.C. Price, C.C. Meltzer, E.L. Moses-Kolho, C. Becker, S.L. Berga, and A.R. Hariri Medial prefrontal cortex serotonin 1A and 2A receptor binding interacts to predict threat-related amygdala reactivity Biol Mood Anxiety Disord 1 2011 2
78. 2 ligands in the treatment of anxiety and depression Expert Opin Investig Drugs 21 2012 1701 1725
79. M.S. Kleven, M.B. Assie, and W. Koek Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats J Pharmacol Exp Ther 282 1997 747 759